# Response Guided Treatment With Direct Acting Anti-Viral Medications for Chronic HCV Infection

> **NCT03603327** · NA · COMPLETED · sponsor: **Soroka University Medical Center** · enrollment: 30 (actual)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** Direct acting anti-viral agents

## Key facts

- **NCT ID:** NCT03603327
- **Lead sponsor:** Soroka University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-25
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-02-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03603327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03603327, "Response Guided Treatment With Direct Acting Anti-Viral Medications for Chronic HCV Infection". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03603327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*